# Metformin and Muscle in Insulin-resistant Older Veterans

Study · id `cardio:ct-nct01804049` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01804049](<https://clinicaltrials.gov/study/NCT01804049>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT01804049

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

## Technical summary

Registry record NCT01804049. Randomized; double masking; primary purpose other. Start 2014-04-08 (actual); primary completion 2018-08-31 (actual). Results posted on 2020-02-11.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose other
- Phase: Phase 1/2
- Enrolled: 120 participants (enrolled count; ClinicalTrials.gov record NCT01804049, source copy `cardio:ctgov-nct01804049-2020-02-11`, retrieved 2026-11-18)
- Started: 2014-04-08 (actual) (ClinicalTrials.gov record NCT01804049, source copy `cardio:ctgov-nct01804049-2020-02-11`, retrieved 2026-11-18)
- Primary completion: 2018-08-31 (actual) (ClinicalTrials.gov record NCT01804049, source copy `cardio:ctgov-nct01804049-2020-02-11`, retrieved 2026-11-18)
- Completion: 2018-08-31 (actual) (ClinicalTrials.gov record NCT01804049, source copy `cardio:ctgov-nct01804049-2020-02-11`, retrieved 2026-11-18)
- Results first posted: 2020-02-11 (ClinicalTrials.gov record NCT01804049, source copy `cardio:ctgov-nct01804049-2020-02-11`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT01804049, source copy `cardio:ctgov-nct01804049-2020-02-11`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01804049-2020-02-11`, retrieved 2026-11-18)

## The registry's words

- Brief title: Metformin and Muscle in Insulin-resistant Older Veterans
- Acronym: M&M
- Condition: Prediabetes
- Intervention (Drug): metformin
- Intervention (Drug): placebo
- Lead sponsor: VA Office of Research and Development
- Lead sponsor class: FED
- Collaborator: Oregon Health and Science University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Prediabetes (`cardio:prediabetes`)
- Registry lists this organization as the lead sponsor: VA Office of Research and Development (`cardio:org-va-office-of-research-and-development`)
- Registry lists this organization as a collaborator: Oregon Health and Science University (`cardio:org-oregon-health-and-science-university`)

## Provenance

Content hash: cf7e7c6e83aec90ae13672db40094ba3a96b4a2c5a3a114adccd0303cb4a0177
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
